FindTrial
Sign In

Standardized application and popularization of fecal microbiota transplantation for treatment of refractory Clostridium difficile infection in children

Standardized application and popularization of fecal microbiota transplantation for treatment of refractory Clostridium difficile infection in children

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-17012121
Enrollment
Unknown
Registered
2017-07-25
Start date
2017-09-30
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric refractory Clostridium difficile infection

Interventions

Treatment Group:FMT

Sponsors

Children's Hospital of Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 14 Years

Inclusion criteria

Inclusion criteria: (1) Aged 1-14 years old, diarrhea more than 3 times a day, laboratory test, CD positive; (2) Recurrent CDI (recurrence more than 3 times); (3) Refractory CDI (conventional vancomycin or other anti CD drugs for 6-8 weeks without curative effect); (4) Legal guardian fully understands and signs informed consent.

Exclusion criteria

Exclusion criteria: (1) Subjects combined with other serious diseases of digestive tract; (2) Subjects combined with other serious diseases of the system.

Design outcomes

Primary

MeasureTime frame
Clostridium difficile;Diarrhea;—

Countries

China

Contacts

Public ContactZhang Ting

Children's Hospital of Shanghai

zhangt@shchildren.com.cn+86 18016487615

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026